NYLIM
SRNE

New York Life Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

New York Life Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-243,451
Closed -$216K – 1451
2022
Q4 		$216K Buy
243,451
+27,438
+13% +$24.3K ﹤0.01% 1171
2022
Q3 		$339K Buy
216,013
+15,867
+8% +$24.9K ﹤0.01% 1052
2022
Q2 		$402K Buy
+200,146
New +$402K ﹤0.01% 958